Release date: September 1, 2008

Expiration Date: July 31, 2011

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 2.0 hours (0.2 CEUs) of continuing education credit (program number 204-000-08-461-H01P).

Accreditation for Physicians

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASHP designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Activity number 08722.

Methods and Format

This activity consists of a self-study continuing education publication, post-test, and activity evaluation tool. Participants must read the entire publication, take the activity post-test, and complete the evaluation to receive continuing education credit. A minimum score of 70% is required on the test to receive continuing education. Upon completion of the online CE test, participants may print their official statements of continuing education credit immediately. The estimated time required to complete this activity is 2 hours. This activity is provided free of charge.

Target Audience

This continuing education activity will be beneficial to managed care professionals including pharmacists, medical directors, managed care executives, pharmacy benefit managers, and others who are involved in health management and research, outcomes management, and pharmacoeconomics.

Activity Content

Click here to view an overview of the activity content.

Learning Objectives

After participating in this educational activity, participants should be able to:

• Describe the clinical and economic burden of acute coronary syndrome (ACS) and venous thromboembolism (VTE).
• Outline current evidence-based guidelines for antiplatelet and anticoagulant therapy in the management of ACS and VTE.
• Summarize the latest clinical research and its potential impact on antiplatelet and anticoagulant therapy in the management of patients with ACS or VTE.
• Describe the role of evidence-based guidelines and performance measurement in improving the quality of care for patients with ACS or VTE and the potential role of managed care pharmacists in the implementation of these guidelines and measures.

Faculty

Michael P. Gulseth, PharmD, BCPS
Assistant Professor
University of Minnesota College of Pharmacy
Clinical Specialist for Anticoagulation Services
St. Mary’s Medical Center
Duluth, Minnesota

Piotr Sobieszczyk, MD
Associate Director
Cardiac Catheterization Laboratory
Brigham and Women’s Hospital
Instructor in Medicine
Harvard Medical School
Boston, Massachusetts

Randall D. Seifert, PharmD
Senior Associate Dean and Professor
Department of Pharmacy Practice and Pharmaceutical Sciences
University of Minnesota College of Pharmacy
Duluth, Minnesota

John Fanikos, MBA, R.Ph.
Assistant Director of Pharmacy
Brigham and Women’s Hospital
Assistant Professor of Clinical Pharmacy
Northeastern University
Massachusetts College of Pharmacy
Boston, Massachusetts

Disclosure Statements

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.

The faculty and planners report the following relationships:

• Randall D. Seifert, PharmD declares that he has no relationships pertinent to this activity.
• Piotr Sobieszczyk, MD declares that he has no relationships pertinent to this activity.
• Michael P. Gulseth, PharmD, BCPS declares that he has served on the speaker’s bureau for Pfizer and has divested himself of this relationship as of December 2007.
• John Fanikos, MBA, R.Ph. declares that he has served on the speaker’s bureau for Eisai Pharmaceuticals, Genentech, GlaxoSmithKline, Schering, The Medicines Company, sanofi-aventis/BMS. He has also served as a consultant for Eisai, GlaxoSmithKline, sanofi-aventis/BMS, and The Medicines Company.

View Supplement and Additional Resources

Supplement: Download PDF of Supplement

Participants are encouraged to complete online introductory courses on acute coronary syndrome and venous thromboembolism prior to reviewing this publication. Visit www.ashpadvantage.com/clot for an online self-assessment tool and links to additional educational programs and resources.

Download Post-Test

Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Learning Center and complete the test online.

This supplement was supported by an educational grant from sanofi-aventis.